In his pioneering work, Okuno and colleagues demonstrated the benefit of musculoskeletal
(MSK) embolization, using imipenem as an embolic agent, in various diseases such as
knee osteoarthritis (KOA), adhesive capsulitis (AC), tennis elbow and other sports
injuries. As imipenem is a last-resort, broad spectrum antibiotic, its use is often
not feasible depending on countries and their drug regulation. Since then, several
other studies have used other material products such as microparticles or liquid embolics.
In addition, several products in development or that are used in other indications
may prove useful after full clinical evaluation of safety and efficacy.
In this article we will develop our recommendations, through an analysis of recent
publications on MSK embolization.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Techniques in Vascular & Interventional RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Midterm clinical outcomes and mr imaging changes after transcatheter arterial embolization as a treatment for mild to moderate radiographic knee osteoarthritis resistant to conservative treatment.J Vasc Interv Radiol JVIR. 2017; 28: 995‑1002
- Clinical Outcomes of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment.J Vasc Interv Radiol JVIR. 2017; 28 (e1): 161-167
- Transcatheter arterial embolization of abnormal vessels as a treatment for lateral epicondylitis refractory to conservative treatment: a pilot study with a 2-year follow-up.J Shoulder Elbow Surg. 2017; 26: 1335‑41
- Characteristics of Imipenem/Cilastatin: Considerations for Musculoskeletal Embolotherapy.J Vasc Interv Radiol JVIR. 2021; 32: 1040-1043
- Imipenem/cilastatin sodium (IPM/CS) as an embolic agent for transcatheter arterial embolisation: a preliminary clinical study of gastrointestinal bleeding from neoplasms.SpringerPlus. 2013; 2: 344
- Osteoarthritis-related knee pain treated with genicular artery embolization: a systematic review and meta-analysis.Orthop J Sports Med. 2021; 923259671211021356
- Genicular Artery Embolization for the Treatment of Knee Pain Secondary to Osteoarthritis.J Vasc Interv Radiol JVIR. 2020; 31: 1096‑102
- Multicenter randomized sham controlled study of genicular artery embolization for knee pain secondary to osteoarthritis.J Vasc Interv Radiol JVIR. 2022; 33: 2-10
- Genicular artery embolization for the treatment of symptomatic knee osteoarthritis.JB JS Open Access. 2021; 6 (e21): 00085
- Genicular artEry embolizatioN in patiEnts with oSteoarthrItiS of the Knee (GENESIS) using permanent microspheres: interim analysis.Cardiovasc Intervent Radiol. 2021; 44: 931‑40
- Short-term results of transcatheter arterial embolization for chronic medial epicondylitis refractory to conservative treatment: a single-center retrospective cohort study.Cardiovasc Intervent Radiol. 2021; 4: juin
- Early results of transcatheter arterial embolization for relief of chronic shoulder or elbow pain associated with tendinopathy refractory to conservative treatment.J Vasc Interv Radiol JVIR. 2018; 29: 510‑7
- Short-term results of transcatheter arterial embolization for chronic medial epicondylitis refractory to conservative treatment: a single-center retrospective cohort study.Cardiovasc Intervent Radiol. 2022; 45: 197‑204
- Mid-term results of transcatheter arterial embolization for adhesive capsulitis resistant to conservative treatment.Cardiovasc Intervent Radiol. 2021; 44: 443‑51
- Results from a US Investigational Device Study of Adhesive Capsulitis Embolization (ACE) in the treatment of Shoulder Pain: the ACE study.J Vasc Interv Radiol JVIR. 2021; (S1051-0443(21)01471-8)
- Treatment of adhesive capsulitis of the shoulder.J Am Acad Orthop Surg. 2019; 27: e544‑54
- Safety and efficacy of embolization with microspheres in chronic refractory inflammatory shoulder pain: a pilot monocentric study on 15 patients.Biomedicines. 2022; 10: 744
- Renal Infarction.StatPearls [Internet]. StatPearls Publishing, Treasure IslandFL2022 (Available at)
- Advances in degradable embolic microspheres: a state of the art review.J Funct Biomater. 2018; 9: E14
- [The new biomaterials of embolization: the shift to degradable].Med Sci MS. 2017; 33: 25‑31
Article info
Publication history
Published online: December 21, 2022
Footnotes
Declaration of Competing Interest: Disclosure Statement for all listed authors. All authors are required to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. A Declaration of Interest (sometimes called a Disclosure Statement) is a notification from the author that there's no financial/personal interest or belief that could affect their objectivity, or if there is, stating the source and nature of that potential conflict. To prevent ambiguity, authors must state explicitly whether potential conflicts do or don't exist, so you may be asked to provide one, even if no conflicts exist. M Sapoval: Consultant for Guerbet and Merit Medical
The name of the institution where the work reported was done (“From...”). From Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
